JP Morgan Maintains Neutral on Chemours, Lowers Price Target to $30
Portfolio Pulse from Benzinga Newsdesk
JP Morgan analyst Jeffrey Zekauskas maintains a Neutral rating on Chemours (NYSE:CC) and lowers the price target from $35 to $30.
May 31, 2023 | 12:23 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
JP Morgan analyst maintains a Neutral rating on Chemours and lowers the price target from $35 to $30.
The news directly mentions Chemours (NYSE:CC) and the lowered price target by JP Morgan analyst Jeffrey Zekauskas. The Neutral rating indicates that the stock is not expected to outperform or underperform the market in the short term. The lowered price target may have a neutral impact on the stock price as it reflects the analyst's updated expectations.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100